In order to develop a new vaccine candidate for equine infectious anemia virus (EIAV), gag gene of Chinese donkey leukocyte attenuated strain (EIAV DLV) and its pa- rental virulent strain (EIAV LN) were inserted respe...In order to develop a new vaccine candidate for equine infectious anemia virus (EIAV), gag gene of Chinese donkey leukocyte attenuated strain (EIAV DLV) and its pa- rental virulent strain (EIAV LN) were inserted respectively into the TK region of the Tiantan strain (VV) of vaccinia virus by homologous recombination and the positive clone was confirmed by blue plaque assay. Protein expression was examined by Western blot. Prime and prime-boost proce- dures were used to immunize mice with two DNA vectors and two recombinant vaccinia viruses expressing EIAV Gag pro- teins. The results showed that the specific lysis of CTL re- sponses in the DNA+rVV groups was stronger than those in the DNA groups, amounting to 31%. Although the levels of specific antibodies were not significantly different, we could conclude that the recombinant vaccinia virus could boost the cellular responses following DNA vector priming. There was no detectable difference between the immune responses in- duced by DLV and LN Gag proteins. This data demonstrates that the combined immunity of DNA vector and recombinant vaccinia virus expressing EIAV gag proteins, utilizing the prime-boost procedure, can drive immunized mice to pro- duce powerful cellular responses. These results lay an im- portant foundation for the development of a new EIAV ge- netic engineering vaccine.展开更多
The human immunodeficiency virus type 1 gag p20 gene fragment was clonedinto plasmid pBV220 to construct a recombinant expression plasmid pCY7.By induction,the p20 protein was expressed in E.coli,and it was confirmed ...The human immunodeficiency virus type 1 gag p20 gene fragment was clonedinto plasmid pBV220 to construct a recombinant expression plasmid pCY7.By induction,the p20 protein was expressed in E.coli,and it was confirmed by Western blotting thatthe expressed p20 protein could be specifically recognized by anti-p17 monoclonalantibodies.The recombinant bacteria was lysed and fractionated into snpernatant andprecipitate by centrifugation.It was found that the p20 protein was present chiefly inthe precipitate.After p20 protein being washed twice,its purity reached 27.4%.Then theprecipitate was washed with 1 mol/L urea solution and the purity of p20 protein wasraised to 58.1%.Finally,the precipitate was dissolved in 6mol/L of urea and appliedonto a heparin affinity column.Four peaks were obtained and the p20 protein wasfound mainly in peak 3.The purity of p20 protein at this step reached 84.2% as meas-ured by gel scanning.展开更多
目的探讨中国流行株 HIV- 1gag与 h IL - 2 /h IL - 6共表达重组核酸疫苗质粒的免疫效果。方法以核酸疫苗质粒 p IRES1neo为表达载体 ,构建重组核酸疫苗质粒 p IRES1- gag、p IRES1- gag- h IL- 2、p IRES1- gag- h IL- 6 ,通过间接免...目的探讨中国流行株 HIV- 1gag与 h IL - 2 /h IL - 6共表达重组核酸疫苗质粒的免疫效果。方法以核酸疫苗质粒 p IRES1neo为表达载体 ,构建重组核酸疫苗质粒 p IRES1- gag、p IRES1- gag- h IL- 2、p IRES1- gag- h IL- 6 ,通过间接免疫荧光试验、Dot- EL ISA检测 gag/h IL - 2 /h IL - 6基因的表达产物。另将此重组核酸疫苗质粒免疫 Balb/c小鼠 ,进行淋巴细胞转化试验、CD4+ 、CD8+ T淋巴细胞数量测定、细胞毒性 T淋巴细胞 (CTL )特异性杀伤作用检测及血清抗体检测 ,结果构建的重组质粒转染 BHK细胞后可表达目的基因 ,免疫小鼠后可有效地刺激淋巴细胞增殖、诱导特异性 CTL 反应 ,当和 h IL- 2 /h IL- 6共表达时免疫效果更加显著。讨论与 Gag蛋白共表达的 h IL- 2 /h IL- 6能够进一步增强免疫鼠的细胞免疫与体液免疫水平 ,构建的重组质粒为 HIV-展开更多
文摘In order to develop a new vaccine candidate for equine infectious anemia virus (EIAV), gag gene of Chinese donkey leukocyte attenuated strain (EIAV DLV) and its pa- rental virulent strain (EIAV LN) were inserted respectively into the TK region of the Tiantan strain (VV) of vaccinia virus by homologous recombination and the positive clone was confirmed by blue plaque assay. Protein expression was examined by Western blot. Prime and prime-boost proce- dures were used to immunize mice with two DNA vectors and two recombinant vaccinia viruses expressing EIAV Gag pro- teins. The results showed that the specific lysis of CTL re- sponses in the DNA+rVV groups was stronger than those in the DNA groups, amounting to 31%. Although the levels of specific antibodies were not significantly different, we could conclude that the recombinant vaccinia virus could boost the cellular responses following DNA vector priming. There was no detectable difference between the immune responses in- duced by DLV and LN Gag proteins. This data demonstrates that the combined immunity of DNA vector and recombinant vaccinia virus expressing EIAV gag proteins, utilizing the prime-boost procedure, can drive immunized mice to pro- duce powerful cellular responses. These results lay an im- portant foundation for the development of a new EIAV ge- netic engineering vaccine.
基金Supported by the National Science Foundation of China No.39100029
文摘The human immunodeficiency virus type 1 gag p20 gene fragment was clonedinto plasmid pBV220 to construct a recombinant expression plasmid pCY7.By induction,the p20 protein was expressed in E.coli,and it was confirmed by Western blotting thatthe expressed p20 protein could be specifically recognized by anti-p17 monoclonalantibodies.The recombinant bacteria was lysed and fractionated into snpernatant andprecipitate by centrifugation.It was found that the p20 protein was present chiefly inthe precipitate.After p20 protein being washed twice,its purity reached 27.4%.Then theprecipitate was washed with 1 mol/L urea solution and the purity of p20 protein wasraised to 58.1%.Finally,the precipitate was dissolved in 6mol/L of urea and appliedonto a heparin affinity column.Four peaks were obtained and the p20 protein wasfound mainly in peak 3.The purity of p20 protein at this step reached 84.2% as meas-ured by gel scanning.
